TTrialPathMatch Me to Trials
← Back to trials
RecruitingGliomaBrain TumorPrimary Brain Tumor

Non-invasive Glioma Characterization Through Molecular Imaging

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.

Sponsor: University of Miami

You may qualify if…

  • Adults (≥18 year old)
  • Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.

You may not qualify if…

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Patients unable to have MRI done

Where it's recruiting

Florida

Miami

Source: ClinicalTrials.gov · NCT03684109 · last updated 2026-04-20

Non-invasive Glioma Characterization Through Molecular Imaging · TrialPath